ATLANTA (Agencies / Eastern Times News) — Amid rising rates of advanced prostate cancer, the American Cancer Society (ACS) has issued updated guidelines recommending routine prostate-specific antigen (PSA) blood screening for men starting at age 50.

Published in CA: A Cancer Journal for Clinicians, the new guidance marks a significant shift from the organization’s 2010 recommendations, which emphasized shared decision-making between patients and doctors. Long-term follow-up studies now show that regular PSA screening reduces the risk of dying from prostate cancer by 13% over 23 years and helps detect aggressive cancers before they spread.
Key Screening Recommendations
- Average-Risk Men (Ages 50–69): A PSA blood test every two years.
- High-Risk Men (Age 45+): Annual PSA testing starting at age 45 for Black men and those with a family history of prostate cancer (such as a father or brother).
- Older Adults (Ages 70–74): Individualized decision-making; if screening is chosen, a PSA test every two years through age 74.
Fewer Unnecessary Biopsies
The updated framework also addresses past concerns over overtreatment. Rather than sending patients straight to a biopsy after a single high PSA reading (3 ng/mL or higher for men under 70, and 6.5 ng/mL or higher for those 70 and older), doctors now repeat the PSA test and utilize modern prostate MRIs and biomarker tests to determine if a biopsy is truly necessary. Experts also noted that digital rectal exams (DRE) add little value to initial screening and are no longer a standard requirement.
